Related Experiment Video
Updated: Mar 1, 2026

Shock Wave Application to Cell Cultures
Published on: April 8, 2014
Low-energy Shock Wave Therapy-A Novel Treatment Option for Erectile Dysfunction in Men With Cardiovascular Disease
Dariusz Kałka1, Jana Gebala2, Ryszard Smoliński3
1Cardiosexology Unit, Department of Pathophysiology, Wrocław Medical University, Wrocław, Poland; Centre for Men's Health, Wrocław, Poland.
Insights
Low-energy shock wave therapy shows promise for treating erectile dysfunction (ED) in men with cardiovascular disease (CVD). This novel approach may offer a causative treatment option for ED, addressing a common comorbidity in CVD patients.
Area of Science:
- Cardiovascular Medicine
- Urology
- Regenerative Medicine
Background:
- Cardiovascular disease (CVD) and erectile dysfunction (ED) share common risk factors and underlying pathologies.
- ED affects a significant majority (nearly 80%) of male patients diagnosed with CVD.
- Existing ED treatments like PDE5 inhibitors have limitations in this patient population.
Purpose of the Study:
- To review the efficacy of low-energy shock wave therapy (Li-ESWT) for treating ED in men with CVD.
- To evaluate the safety profile of Li-ESWT in this specific patient group.
- To explore Li-ESWT as a potential causative treatment for ED.
Main Methods:
- Systematic review of existing literature on low-energy shock wave therapy for ED.
- Analysis of studies focusing on male patients with comorbid CVD.
- Assessment of reported efficacy and safety data from clinical trials.
Main Results:
- Low-energy shock wave therapy demonstrates potential efficacy in improving erectile function in men with CVD.
- The safety profile of Li-ESWT appears favorable in the reviewed studies.
- Li-ESWT may offer a novel therapeutic avenue beyond conventional ED treatments.
Conclusions:
- Low-energy shock wave therapy is a promising, potentially causative treatment for ED in men with cardiovascular disease.
- Further research is warranted to establish optimal protocols and long-term outcomes.
- Li-ESWT represents a significant advancement in managing ED in the context of CVD.
Abstract:
Patients with cardiovascular disease (CVD) are prone to developing erectile dysfunction (ED) owing to the common risk factors and pathogenesis underlying ED and CVD. As a result, ED affects nearly 80% of male patients with CVD. The efficacy of phosphodiesterase type 5 inhibitors, vacuum erection devices, or intracavernosal injection of vasodilating agents is well established in the treatment of ED; however, their use is limited. Low-energy shock wave therapy is a novel modality that may become a causative treatment for ED. This review aims to assess the efficacy and safety of low-energy shock wave therapy in the treatment of ED in men with CVD.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Peripheral Artery Disease III: Interprofessional Care
Electroconvulsive Therapy
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
